title: P2X7 nucleotide receptor signaling potentiates the Wnt/β-catenin pathway in cells of the osteoblast lineage.
abstract: The P2X7 and Wnt/β-catenin signaling pathways regulate osteoblast differentiation and are critical for the anabolic responses of bone to mechanical loading. However, whether these pathways interact to control osteoblast activity is unknown. The purpose of this study was to investigate the effects of P2X7 activation on Wnt/β-catenin signaling in osteoblasts. Using MC3T3-E1 cells, we found that combined treatment with Wnt3a and the P2X7 agonist 2'(3')-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP) elicited more sustained β-catenin nuclear localization than that induced by Wnt3a alone. Wnt3a-induced increases in β-catenin transcriptional activity were also potentiated by treatment with BzATP. Consistent with involvement of P2X7, a high ATP concentration (1 mM) potentiated Wnt3a-induced β-catenin transcriptional activity, whereas a low concentration (10 μM) of ATP, adenosine 5'-diphosphate (ADP), or uridine 5'-triphosphate (UTP) failed to elicit a response. The potentiation of β-catenin transcriptional activity elicited by BzATP was also inhibited by two distinct P2X7 antagonists: A 438079 and A 740003. Furthermore, responses to Wnt3a in calvarial cells isolated from P2rx7 knockout mice were significantly less than in cells from wild-type controls. In MC3T3-E1 cells, BzATP increased inhibitory phosphorylation of glycogen synthase kinase 3β (GSK3β), a process that was blocked by A 438079 and diminished by inhibition of protein kinase C. Thus, P2X7 signaling may potentiate the canonical Wnt pathway through GSK3β inhibition. Taken together, we show that P2X7 activation prolongs and potentiates Wnt/β-catenin signaling. Consequently, cross-talk between P2X7 and Wnt/β-catenin pathways may modulate osteoblast activity in response to mechanical loading.
authors.affiliation: Department of Anatomy and Cell Biology, The University of Western Ontario, London, ON, Canada.|Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Grol
authors.affiliation: Schulich Dentistry, The University of Western Ontario, London, ON, Canada.|Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
authors.forename: Patricia J
authors.initials: PJ
authors.lastname: Brooks
authors.affiliation: Department of Physiology and Pharmacology, The University of Western Ontario, London, ON, Canada.
authors.forename: Alexey
authors.initials: A
authors.lastname: Pereverzev
authors.affiliation: Schulich Dentistry, The University of Western Ontario, London, ON, Canada. jeff.dixon@schulich.uwo.ca.|Department of Physiology and Pharmacology, The University of Western Ontario, London, ON, Canada. jeff.dixon@schulich.uwo.ca.|Bone and Joint Institute, The University of Western Ontario, London, ON, Canada. jeff.dixon@schulich.uwo.ca.
authors.forename: S Jeffrey
authors.initials: SJ
authors.lastname: Dixon
mesh_terms: D000818:Animals; D015153:Blotting, Western; D005455:Fluorescent Antibody Technique; D051379:Mice; D018345:Mice, Knockout; D010006:Osteoblasts / Q000378:metabolism*; D058486:Receptors, Purinergic P2X7 / Q000378:metabolism*; D060449:Wnt Signaling Pathway / Q000502:physiology*
chemical_list: D058486:Receptors, Purinergic P2X7
keywords: Glycogen synthase kinase 3β; Osteoblast; P2X7 receptors; Wnt; β-catenin